DURHAM, N.C.--(BUSINESS WIRE)--Argos Therapeutics today announced that Tamara Monesmith, Director of Manufacturing and Process Development, will present details on the Company’s automated approach to manufacturing personalized dendritic cell immunotherapies. The Company’s advanced manufacturing process is complementary to its Arcelis™ technology, a proprietary platform for creating personalized immunotherapies for HIV, other infectious diseases, and cancer. The presentation will take place at the IBC Next Generation Vaccines Conference in National Harbor, MD, on July 17, 2008.
